Company: SCYX
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0000950170-25-038044
Chunk: 123

Company: SCYNEXIS INC
Filing Date: 2025-03-12
Form: 10-K
Item: Item 1B
Chunk 123
---
    Deferred revenue, current portion

    1,642

    1,189

    Operating lease liability, current portion (Note 7)

    407

    340

    Warrant liabilities

    —

    130

    Convertible debt and derivative liability (Note 6)

    13,688

    —

    Total current liabilities

    24,099

    16,303

    Deferred revenue

    1,294

    2,727

    Warrant liabilities

    7,998

    21,680

    Convertible debt and derivative liability (Note 6)

    —

    12,159

    Operating lease liability (Note 7)

    2,175

    2,581

    Total liabilities

    35,566

    55,450

    Commitments and contingencies

    Stockholders’ equity:

    Preferred stock, $0.001 par value, authorized 5,000,000 shares as of December 31, 2024 and December 31, 2023; 0 shares issued and outstanding as of December 31, 2024 and December 31, 2023

    —

    —

    Common stock, $0.001 par value, 150,000,000 shares authorized as of December 31, 2024 and 2023; 37,973,991 and 37,207,799 shares issued and outstanding as of December 31, 2024, and December 31, 2023, respectively

    41

    40

    Additional paid-in capital

    431,571

    428,169

    Accumulated deficit

    (376,535
    )

    (355,247
    )

    Total stockholders’ equity

    55,077

    72,962

    Total liabilities and stockholders’ equity
     
    $
    90,643

    $
    128,412

The accompanying notes are an integral part of the financial statements.

59

SCYNEXIS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)

    Years Ended December 31,

    2024

    2023

    Revenue:

    Product revenue, net
     
    $
    —

    $
    1,044

    License agreement revenue